Until

Head of Quality & Regulatory Affairs

Until  •  United States (Hybrid)  •  7 days ago
Apply
AI can make mistakes so check important info. Chat history is never stored.
63
AI Success™

Job Description

Until is a moonshot company building a “pause button” for biology. Our near-term focus is organ-scale reversible cryopreservation: preserving donated organs at subzero temperatures without ice formation, then rewarming them uniformly for transplant. By solving this grand challenge, we’re laying the foundation for whole-body reversible cryopreservation, giving patients a bridge to future cures.
To achieve our goal, we are assembling an interdisciplinary team to develop perfusion systems, cryoprotectant formulations, and vitrification and rewarming hardware.
We envision a future where no transplantable organ is lost to logistics, and no terminal diagnosis is final because patients can safely wait for future medicine to arrive.
We are seeking a Head of Quality & Regulatory Affairs to own and scale our quality system and regulatory strategy as we advance from pre-clinical development into clinical trials and early commercialization.
This role is both strategic and hands-on You will design and implement a fit-for-purpose QMS, define regulatory pathways, lead agency interactions, and act as the internal authority on quality, compliance, and risk. You will be a core member of the leadership team and a key partner to R&D, Manufacturing, Clinical, and Operations.

Key Responsibilities

  • Design, implement, and maintain a scalable Quality Management System (QMS) aligned with: FDA (21 CFR 820, 21 CFR 210/211 as applicable), ISO 13485 / ISO 9001 (as appropriate), GLP / GCP / GMP interfaces
  • Own quality governance including: SOPs, change control, CAPAs, deviations, complaints, Risk management (ISO 14971), Document control and training systems
  • Serve as the final authority on quality decisions, balancing speed with compliance
  • Lead internal audits and support external audits, inspections, and partner diligence
  • Define and own the regulatory strategy across product lines (device, biologic, combination product, or hybrid pathway as applicable)
  • Lead FDA interactions including: Pre-Subs / Q-Subs, IND / IDE strategy (as applicable), briefing documents and meeting leadership
  • Advise leadership on regulatory risk, sequencing, and trade-offs
  • Interface with global regulators as needed (EMA, MHRA, etc.)
  • Embed quality and regulatory thinking early into: R&D and preclinical study design, manufacturing process development, vendor qualification and tech transfer
  • Partner closely with: R&D / Preclinical, Clinical, Manufacturing & Supply chain, Operations & Program Management
  • Act as a translator between technical teams and regulators
  • Initially operate as a player-coach / IC
  • Hire and develop QA and RA team members over time
  • Establish external partner strategy (consultants, CROs, notified bodies, etc.)
  • Build systems that will scale through clinical trials and toward commercialization

Qualifications

  •  5+ years of experience in Quality, Regulatory Affairs, or combined QA/RA in biotech, medtech, or combination products
  • Direct experience building or scaling a QMS in an early- or mid-stage company
  • Hands-on experience leading FDA interactions (Pre-Sub, IND, IDE, or equivalent)
  • Strong working knowledge of: FDA regulations (21 CFR 820, 210/211, 11 as relevant), ISO 13485 and risk management frameworks
  • Track record of sound judgment in ambiguous, fast-moving environments
  • Ability to operate at both strategic and execution levels

Preferred / Nice to Have

  • Experience with IDE, first-in-human or novel modalities
  • Combination product or platform technology experience
  • Prior inspection or audit leadership experience
  • Experience in organ preservation, devices, biologics, or translational research (context-dependent)
Until

About Until

We are building reversible cryopreservation technology to solve the organ procurement and matching problem.

Cryopreservation is already essential to modern medicine — powering IVF and life-saving stem cell therapies.

Now, we’re extending this technology to whole human organs — transforming hours of viability into weeks, or months, however long is necessary — so that no donated organ is lost to logistics, and no patient dies waiting.

By solving this immediate need, we de-risk and build the foundation for what comes next: whole-body reversible cryopreservation. We're pausing molecular motion to give patients a bridge to future cures.

Industry
Biotech & Life Sciences
Company Size
11-50 employees
Headquarters
San Francisco , California
Year Founded
Unknown
Social Media